loader from loading.io

Solidarity Fridays - Week 15

Psychedelics Today

Release Date: 07/10/2020

Del Jolly - Psilocybin, Concussions and Unlimited Sciences' Mission show art Del Jolly - Psilocybin, Concussions and Unlimited Sciences' Mission

Psychedelics Today

In this episode, Joe interviews Del Jolly: co-founder and Director of psychedelic research nonprofit Unlimited Sciences, previous Business Development Manager at Charlotte's Web, previous Outreach Director for Decriminalize Denver, and member of the Board of Advisors for cannabis nonprofit, The Realm of Caring. Jolly talks about his path to Unlimited Sciences and its purpose: to collect as much data as possible through an observational research study through Johns Hopkins University, where participants are asked to provide as many details as possible about their psilocybin use. Like "Cannabis...

info_outline
Solidarity Fridays - Week 26 show art Solidarity Fridays - Week 26

Psychedelics Today

In today’s Solidarity Fridays episode, Joe and Kyle sit down and discuss recent items in the news. They first discuss an update to last week's Michigan story: that this week, the Ann Arbor city council unanimously voted to decriminalize entheogenic plants. While this is great progress, remember that these substances are still illegal- just decriminalized, and as the saying goes: don't be the low-hanging fruit. This brings up the concept of likening the ability to get these substances to earning (and keeping) a driver's license, and the idea of temporary autonomous zones.  Next, they...

info_outline
Vanessa LeMaistre - Embracing a Path to Spiritual Discovery show art Vanessa LeMaistre - Embracing a Path to Spiritual Discovery

Psychedelics Today

In this episode, Joe interviews shaman, motivational speaker, author, minister, and healer, Vanessa LeMaistre.  LeMaistre talks about her path towards shamanism: from being told she was different as a child, to traveling to India at 25 and falling in love with yoga and meditating on the Ganges river, to a tarot card reading inspiring her to earn her Master's degree at Naropa University, to trying coca for the first time (without realizing ahead of time that that's what she'd be doing), to training with Michael Harner. Ultimately, what led her towards accepting her fate as a shaman was...

info_outline
Solidarity Fridays - Week 25 show art Solidarity Fridays - Week 25

Psychedelics Today

In today’s Solidarity Fridays episode, Joe and Kyle discuss recent items in the news and dive into cannabis-assisted psychotherapy after Joe recently helped with his first session. They discuss Compass Pathways' projection that their upcoming stock price could be $14-$16 a share, giving them a possible valuation of as much as $544 million and the problem of having Peter Thiel as one of their leading investors, as it has recently come to surface that he met with white nationalists in 2016 and had good things to say about them. This, in addition to his concerning data-mining company, Palantir...

info_outline
Ash - CBD, Nootropics, and Micro1p show art Ash - CBD, Nootropics, and Micro1p

Psychedelics Today

In this episode, Joe interviews Ash: Netherlands-based psychedelic entrepreneur with his hands in many psychedelic spaces- drug manufacturing company Synergy Trading, nootropics company Cerebra Nootropics, and podcast, Shifty Perspective.   Ash talks about his path from trying San Pedro on a farm, to trying DMT and living on the road and in squats for years, to moving to Belgium from the UK, to finding his way into the world of CBD after a friend recommended it for his epileptic girlfriend at the time. When she went from 12 seizures a day to none within a month of starting regular...

info_outline
Solidarity Fridays - Week 24 show art Solidarity Fridays - Week 24

Psychedelics Today

In today's Solidarity Fridays episode, Joe and Kyle discuss several recent items in the news that further the advancement of psychedelics, including: Canadian company Havn Lifescience following Compass Pathways' lead and registering with the Canadian Securities Exchange under the symbol HAVN, Amsterdam-based psychedelic retreat company Synthesis announcing that leading Clinical Psychologist Dr. Rosalind Watts has joined their advisory board (which also includes Dr. Robin Carhart-Harris, who joined in November), European psychedelic-assisted psychotherapy company AWAKN Life Sciences Inc....

info_outline
Wade Davis - Ayahuasca and a New Hope for Colombia show art Wade Davis - Ayahuasca and a New Hope for Colombia

Psychedelics Today

In this episode, Joe interviews Wade Davis: Ph.D., Professor of Anthropology at the University of British Columbia, explorer, ethnobotanist, star of the recent documentary, "El Sendero de la Anaconda," and author of several books, including  bestseller The Serpent and the Rainbow, which was optioned for a movie, starring Bill Pullman and released by Universal Pictures in 1988. His new book, Magdalena: River of Dreams: A Story of Colombia, comes out on September 15th.  Wade discusses his history with Richard Evans Schultes, the strange phenomenon behind the growth of ayahuasca...

info_outline
Solidarity Fridays - Week 23 show art Solidarity Fridays - Week 23

Psychedelics Today

In today's Solidarity Fridays episode, Joe and Kyle discuss recent items in the news. They cover a new LSD microdose trial to study the effects of 5, 10, or 20 µg on acute pain, seeing how long participants could hold their hands in 37.4° F water. Led by researchers from Maastricht University with help from the Beckley Foundation, this is the first study of its kind since Eric Kast first studied the effects of LSD on acute pain in the 1960s, and could help lead to LSD being prescribed for acute pain over the more standard and very addictive and dangerous opioids. This leads towards the topic...

info_outline
Sara Reed - Ketamine Therapy Through a Culturally Responsible Lens show art Sara Reed - Ketamine Therapy Through a Culturally Responsible Lens

Psychedelics Today

In this episode, Joe and Kyle interview Sara Reed, MS, LMFT, creator of Mind's Eye Health Solutions, and Director of Psychedelic Services at the Behavioral Wellness Clinic in Connecticut. Reed talks about her path to psychedelics- from graduating with a masters in emerging family therapy and wanting to do research specifically with black Americans, to working with Dr. Monica Williams and eventually MAPS, to being selected as one of the therapists for a phase 3 MDMA-assisted psychotherapy trial (which focused on people of color), to making the transition from practicing with MDMA to ketamine...

info_outline
Solidarity Fridays - Week 22 show art Solidarity Fridays - Week 22

Psychedelics Today

In today's Solidarity Fridays episode, Joe and Kyle have, in Joe's words, "a wildly rambling show." They cover topics in the news, including MAPS' recent completion of their Capstone Campaign, a non-profit fundraising effort to fund the final research required to seek FDA approval of MDMA-assisted psychotherapy (through which they raised $30 million from several high-profile names), MindMed's new LSD-MDMA "candy flipping" phase 1 trial set to commence later this year, Representative Earl Blumenauer's (D-OR) fundraising efforts for legal psilocybin and Oregon's ballot initiative becoming a...

info_outline
 
More Episodes

In today’s Solidarity Fridays episode, Joe and Kyle sit down and talk about various topics in the news.

They first discuss Rise Wellness (a company focused on teaching people how to microdose psilocybin)'s recent merger with CannaGlobal and Sansero Life Sciences to become CannaGlobal Wellness, and why many smaller companies are merging, and why Canada may be a hot new destination point for these companies. Joe suggests a new idea of helping people microdose through the use of a transdermal patch. 

They talk about psychology today and the idea of no theory being complete without including all perspectives (including psychedelic perspectives), the concept of re-phrasing “what’s wrong with you?” to “what has happened to you?”, a recent student’s theory that schizophrenia may actually be a protection mechanism, Amsterdam-based psilocybin-retreat company Synthesis’ recent $2.75 million funding towards developing an end-to-end professional wellness & therapy platform, and what that means to the community- are these companies focusing on the drug as the crux, or the full therapy picture?

Lastly, they talk about the death of Elijah McClain from a 500-milligram injection of ketamine, using thoughts from past guest and regular administrator of ketamine to patients, Dr. Alex Belser. They talk about how ketamine can be necessary, but how it has unfortunately been used as a weapon for chemical restraint against people of color, which brings about larger questions on whether people should be allowed to hurt themselves or not- what role do physicians, therapists and police officers ultimately have in people’s freedom to do what they want with their bodies? 

And just as a reminder, Psychedelics Today is currently offering a course developed by Kyle and Dr. Ido Cohen called Psychedelics and The Shadow: The Shadow Side of Psychedelia. And the next round of Navigating Psychedelics for Clinicians and Therapists will be starting in September, with a new self-paced option. 

Notable Quotes

On William James: “As soon as he found out about other states of consciousness other than the normal waking state, he’s saying that no theory for how the world works is complete unless we include all perspectives. So, like, what is the American constitution when you’re on nitrous or on LSD? What is appropriate political idealogy, given all of these things? Essentially, he’s saying that we’re going to keep developing new tools to understand the universe, and every time we have one of these new tools, it kind of expands the scope of what we need in our theories for how the world works. ...Psychedelic states, shamanic states- how do we include that into our worldview to have a complete scientific framework? I think it’s just a never-ending process, and a fun one.” -Joe

“Even the people that I’ve worked with [who] are really really struggling, and I’ve seen medication work really well for them at times, I always come back to: ‘what has this person been through? Do they actually have this thing that science and probably psychiatry would label as a disease?’ ...Some of the trauma stuff that’s coming out, the neuroscience, some of the somatics- it’s all kind of merging. And with the help of psychedelics, I’m feeling more optimistic that maybe the field will go into more of a growth, healing-oriented route vs. this pathology [of] ‘sick.’” -Kyle

“With these clinics that are popping up- are you exclusively focusing on the psychedelic experience, or are you trying to focus on the therapeutic relationship, the rapport, the container, the trust that’s developed over time, and really developing that relationship with the client? There’s tons of research that suggests that a therapeutic relationship is the one factor in getting better in therapy. So, as money is coming into this space and more of these clinics are popping up, are you creating a center around therapy, and really thinking about how to bring wellness and work with people in this space, or are just focusing it exclusively on the substance, thinking that’s the change?” -Kyle

Links

CannaGlobal, Sansero Life Sciences and Rise Wellness Merge

Synthesis Raises US$2.75M to Develop End-to-End Professional Platform for Psychedelic Wellness & Therapy

Alex Belser's thoughts on ketamine as a chemical restraint

Is Ketamine the new police weapon against black lives?

Psychedelics and The Shadow: The Shadow Side of Psychedelia

Support the show

Navigating Psychedelics